COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,281 Articles (22,759 medRxiv, 8,522 bioRxiv)

Most recent first Previous |  Page 1102: Articles 11011-11020  | Next

Possible Interference in Protein - Protein interaction as a new approach in microinhibition of respiratory pathogens on nasal- oral epithelium: An early on-screen study with reference toSARS-Cov-2-ACE2 binding interference
Datta, D., Pant, S., Dhaked, D. K., Arumugam, S., Velayutham, R., Datta, P.
10.1101/2021.12.01.470353 — Posted: 2021-12-03
Delta variant with P681R critical mutation revealed by ultra-large atomic-scale ab initio simulation: Implications for the fundamentals of biomolecular interactions
Adhikari, P., Jawad, B., Rao, P., Podgornik, R., Ching, W.-Y.
10.1101/2021.12.01.470802 — Posted: 2021-12-03
Internal Tremors and Vibration Symptoms Among People with Post-Acute Sequelae of SARS-CoV-2: A narrative review of patient reports
Massey, D., Baker, A. D., Baker, A. D., Guthe, N., Pincus Shidlovsky, S., Fisher, L., Fisher, L., Pincus Shidlovsky, S., Sharma, R., Krumholz, H.
10.1101/2021.12.03.21267146 — Posted: 2021-12-03 Discussion: Onsite
Humoral responses following SARS-CoV-2 breakthrough infection in COVID-19 vaccinated individuals
Lechmere, T., Snell, L. B., Graham, C., Seow, J., Shalim, Z. A., Charalampous, T., Alcolea-Medina, A., Batra, R., Nebbia, G., Edgeworth, J. D., Malim, M. H., Doores, K. J.
10.1101/2021.12.01.21266982 — Posted: 2021-12-02
Third COVID-19 Vaccine Dose Boosts Neutralising Antibodies in Poor Responders
Lake, D., Roeder, A. J., Gonzalez-Moa, M. J., Koehler, M., Kaleta, E., Jasbi, P., Vanderhoof, J., Mckechnie, D., Forman, J., Edwards, B., Seit-Nebi, A., Svarovsky, S.
10.1101/2021.11.30.21266716 — Posted: 2021-12-02
Variance in Variants: Propagating Genome Sequence Uncertainty into Phylogenetic Lineage Assignment
Champredon, D., Becker, D. G., Chato, C., Gugan, G., Poon, A. G.
10.1101/2021.11.30.470642 — Posted: 2021-12-02
Digital exclusion predicts worse mental health among adolescents during COVID-19
Metherell, T. E., Ghai, S., McCormick, E. M., Ford, T. J., Orben, A.
10.1101/2021.11.25.21266853 — Posted: 2021-12-02
Medical Students' Perceptions of Learning and Working on the COVID-19 Frontlines: "...a confirmation that I am in the right place professionally."
Klasen, J. M., Schoenbaechler, Z., Bogie, B., Meienberg, A., Nickel, C., Bingisser, R., LaDonna, K.
10.1101/2021.12.01.21267145 — Posted: 2021-12-02
Estimating the increase in reproduction number associated with the Delta variant using local area dynamics in England
Abbott, S., CMMID COVID-19 Working Group, , Kucharski, A., Funk, S.
10.1101/2021.11.30.21267056 — Posted: 2021-12-02
A simple model of COVID-19 explains disease severity and the effect of treatments
Sanche, S., Cassidy, T., Chu, P., Perelson, A. S., Ribeiro, R. M., Ke, R.
10.1101/2021.11.29.21267028 — Posted: 2021-12-02

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).